use
polymeras
chain
reaction
pcr
centrifugationenhanc
viral
cultur
method
character
virus
caus
acut
respiratori
infect
adult
influenza
season
method
januarymarch
nasopharyng
wash
specimen
previous
healthi
adult
present
respiratori
symptom
evalu
viral
pathogen
centrifugationenhanc
viral
cultur
pcr
diagnos
case
includ
unspecifi
upper
respiratori
infect
case
acut
bronchiti
sinus
pharyng
pneumonia
use
shell
vial
assay
pcr
identifi
pathogen
patient
includ
influenza
b
picornaviru
includ
rhinoviru
respiratori
syncyti
viru
rsv
human
metapneumoviru
human
coronaviru
adenoviru
parainfluenza
viru
type
coinfect
influenza
parainfluenza
viru
type
conclus
find
demonstr
even
influenza
season
rhinoviru
rsv
preval
must
consid
differenti
diagnosi
adult
acut
respiratori
infect
prescrib
antivir
medic
human
coronaviru
human
metapneumoviru
play
substanti
role
pcr
especi
use
tool
identif
influenza
viral
pathogen
easili
detect
tradit
test
method
communityacquir
respiratori
infect
adult
contribut
substanti
morbid
mortal
although
often
selflimit
infect
lead
lost
day
work
increas
medic
cost
sever
ill
even
death
histor
etiolog
acut
respiratori
ill
ari
difficult
defin
although
isol
pathogen
frequent
find
found
case
like
repres
viral
pathogen
diagnost
test
unabl
detect
although
frequent
overlap
histor
rhinovirus
human
coronavirus
adenovirus
commonli
associ
upper
respiratori
tract
infect
eg
common
cold
otiti
media
sinus
wherea
influenza
respiratori
syncyti
viru
rsv
parainfluenza
virus
commonli
found
case
lower
respiratori
tract
infect
eg
acut
bronchiti
bronchiol
pneumonia
although
use
limit
primarili
refer
laboratori
research
set
new
molecular
diagnost
techniqu
may
offer
better
sensit
specif
detect
respiratori
agent
offer
current
standard
clinic
method
eg
antigen
detect
isol
past
decad
pcr
technolog
improv
understand
burden
respiratori
virus
tradit
difficult
detect
routin
method
human
metapneumoviru
rhinoviru
rsv
human
coronaviru
howev
mani
studi
employ
pcr
techniqu
test
singl
limit
number
respiratori
agent
other
focus
specif
popul
eg
pediatr
patient
elderli
person
specif
underli
ill
eg
adult
chronic
lung
diseas
focus
outbreak
set
studi
use
centrifugationenhanc
viral
cultur
rmix
fresh
cell
diagnost
hybrid
pcr
techniqu
test
respiratori
virus
previous
healthi
popul
adult
goal
first
better
character
spectrum
viral
agent
caus
ari
second
compar
sensit
newer
molecular
techniqu
convent
method
diagnos
viral
respiratori
pathogen
januarymarch
consecut
adult
age
year
seek
care
univers
california
san
francisco
ucsf
acut
ambulatori
care
clinic
emerg
depart
symptom
ari
elig
particip
ucsf
tertiari
care
univers
hospit
larg
associ
primari
care
clinic
ucsf
acut
ambulatori
care
clinic
primari
referr
clinic
patient
sent
ucsf
primari
care
clinic
evalu
nonurg
medic
problem
wherea
emerg
depart
evalu
acut
ill
patient
symptom
ari
defin
develop
new
ill
within
past
week
cough
sinu
pain
congest
sore
throat
fever
patient
follow
noninfecti
selfreport
condit
exclud
pregnanc
system
inflammatori
disord
eg
rheumatoid
arthriti
system
lupu
erythematosu
inflammatori
bowel
diseas
coexist
infect
sever
tissu
damag
within
previou
day
eg
trauma
surgeri
burn
myocardi
infarct
unstabl
angina
cancer
metastat
untreat
aid
immunosuppress
disord
train
research
assist
continu
review
triag
note
identifi
potenti
elig
patient
patient
identifi
standard
encount
form
use
ascertain
patient
age
race
ethnic
underli
medic
condit
clinic
sign
symptom
clinic
diagnosi
assign
evalu
clinician
record
free
text
area
form
diagnos
depend
individu
clinician
judgment
diagnos
may
mutual
exclus
patient
subsequ
evalu
treat
clinician
usual
manner
medic
record
review
perform
ascertain
vital
sign
physic
examin
find
diagnos
treatment
studi
patient
receiv
gift
certif
time
studi
protocol
procedur
review
approv
ucsf
committe
human
research
laboratori
method
time
enrol
nasopharyng
wash
specimen
obtain
use
cc
normal
salin
place
viral
transport
media
aliquot
multipl
steril
tube
store
c
collect
convent
swab
sampl
routin
test
bacteria
perform
primari
object
studi
examin
frequenc
pathogen
caus
acut
bronchiti
group
streptococcu
encapsul
bacteria
eg
streptococcu
pneumonia
haemophilu
influenza
moraxella
cattarhali
thought
common
caus
acut
bronchiti
adult
without
underli
lung
diseas
specimen
inocul
duplic
rmix
fresh
cell
shell
vial
cultur
coverslip
diagnost
hybrid
cultur
c
h
rmix
fresh
cell
combin
mink
lung
cell
human
adenocarcinoma
cell
sensit
convent
cultur
rel
rapid
turnaround
time
cultur
termin
cell
scrape
coverslip
spot
onto
multiwel
slide
airdri
fix
methanol
initi
cell
prepar
stain
direct
immunofluoresc
assay
use
polyval
antibodi
bartelstrin
biotechnolog
direct
virus
influenza
b
rsv
adenoviru
parainfluenza
viru
type
duplic
cultur
posit
result
stain
use
virusspecif
monoclon
antibodi
total
nucleic
acid
extract
respiratori
specimen
use
masterpur
complet
dna
rna
purif
kit
epicentr
technolog
convent
rtpcr
assay
perform
accord
erdman
et
al
primer
adenoviru
influenza
b
rsv
parainfluenza
viru
type
parainfluenza
viru
type
human
metapneumoviru
human
coronaviru
forward
primer
human
coronaviru
revers
primer
picornaviru
inclus
rhinoviru
enteroviru
erdman
person
commun
differenti
rhinoviru
enteroviru
rtpcr
process
modifi
kare
et
al
realtim
rtpcr
assay
use
improv
sensit
rsv
confirm
convent
rtpcr
find
influenza
realtim
rtpcr
assay
use
lindstrom
person
commun
data
analysi
univari
procedur
use
examin
distribut
ill
characterist
physic
examin
find
laboratori
result
statist
test
comparison
includ
x
test
dichotom
variabl
test
normal
distribut
continu
variabl
wilcoxon
rank
sum
test
nonnorm
distribut
variabl
statist
analysi
perform
use
sa
softwar
sa
institut
studi
perform
januarymarch
midst
peak
influenza
activ
measur
region
trend
outpati
visit
influenzalik
ill
influenzaassoci
hospit
laboratori
detect
influenza
northern
california
total
patient
ucsf
acut
ambulatori
care
among
case
diagnosi
upper
respiratori
infect
common
agent
influenza
found
case
among
patient
diagnosi
bronchiti
common
agent
picornaviru
found
patient
case
agent
classifi
rhinoviru
follow
influenza
patient
small
number
case
sinus
pharyng
pneumonia
detect
agent
list
tabl
use
pcr
shell
vial
assay
viral
agent
detect
total
case
tabl
viru
detect
shell
vial
assay
patient
wherea
pcr
identifi
viru
patient
note
pcr
identifi
influenza
case
shell
vial
assay
specif
target
pcr
identifi
addit
virus
assess
shell
vial
assay
includ
picornaviru
case
human
metapneumoviru
human
coronaviru
case
picornaviru
infect
addit
pcr
test
differenti
due
rhinoviru
picornavirus
could
classifi
basi
sensit
assay
compar
shell
vial
assay
pcr
identifi
addit
case
influenza
case
parainfluenza
viru
type
case
patient
neg
result
accord
shell
vial
assay
fail
detect
case
patient
posit
result
accord
shell
vial
assay
influenza
patient
adenoviru
patient
parainfluenza
viru
type
infect
patient
influenza
dispar
influenza
subtyp
seen
case
shell
vial
assay
could
distinguish
influenza
b
case
identifi
influenza
b
case
type
influenza
accord
differ
pcr
method
use
shell
vial
assay
gold
standard
convent
influenza
rtpcr
assay
show
sensit
specif
posit
neg
predict
valu
respect
second
rtpcr
assay
influenza
show
concord
pcrposit
shell
vial
assayneg
sampl
sampl
consid
true
posit
valu
increas
respect
clinic
sign
symptom
common
viral
pathogen
list
tabl
compar
patient
infect
influenza
infect
rhinoviru
rsv
patient
influenza
like
myalgia
patient
influenza
like
fever
p
compar
patient
rhinoviru
p
trend
toward
associ
fever
rsv
p
p
howev
small
number
patient
rsv
group
limit
power
detect
signific
differ
n
p
patient
infect
rhinoviru
rsv
like
wheez
examin
other
p
studi
appli
comprehens
diagnost
test
enabl
identif
viral
agent
almost
previous
healthi
adult
present
evalu
ari
influenza
account
onehalf
pathogen
identifi
frequent
detect
pathogen
includ
picornaviru
confirm
rhinoviru
compris
onequart
identifi
etiolog
rsv
detect
rate
almost
pcr
somewhat
greater
found
similar
studi
attempt
determin
etiolog
viral
ari
healthi
adult
use
nonmolecular
method
tecumseh
studi
larg
longitudin
prospect
studi
commun
ari
begun
detect
viral
agent
isol
adult
year
old
anoth
earli
studi
upper
respiratori
infect
involv
adult
identifi
viral
etiolog
use
isol
method
patient
use
combin
isol
serolog
test
studi
involv
colleg
student
respiratori
symptom
found
etiolog
patient
later
studi
adult
ari
use
combin
cultur
elisa
immunostain
techniqu
yield
viral
etiolog
patient
age
year
patient
age
year
improv
detect
rate
pcr
specif
individu
respiratori
agent
eg
rhinoviru
enteroviru
human
coronaviru
parainfluenza
viru
shown
other
studi
one
compar
pcr
nonmolecular
method
broad
array
pathogen
studi
pcr
substanti
sensit
isol
shell
vial
techniqu
detect
influenza
identifi
almost
case
shell
vial
assay
pcr
gave
advantag
shell
vial
assay
detect
rsv
influenza
b
adenoviru
parainfluenza
viru
type
popul
howev
pcr
especi
use
identifi
pathogen
frequent
detect
convent
note
trend
toward
associ
fever
rsv
compar
influenza
howev
small
number
patient
rsv
group
n
p
limit
p
p
power
detect
signific
differ
flu
influenza
rsv
respiratori
syncyti
viru
tm
tympan
membran
influenza
b
versu
picornaviru
b
influenza
b
versu
rsv
diagnost
techniqu
includ
rhinoviru
human
metapneumoviru
human
coronaviru
exampl
rhinoviru
tradit
consid
import
winter
pathogen
earli
epidemiolog
studi
demonstr
distinct
season
rhinoviru
infect
high
incid
occur
fall
spring
temper
region
major
peak
fall
presum
result
children
return
school
studi
conduct
winter
month
specif
focus
adult
also
found
low
preval
ari
caus
rhinoviru
studi
reli
culturebas
method
may
underestim
true
rate
infect
howev
recent
studi
use
pcr
also
identifi
high
incid
rhinoviru
infect
spring
fall
rhinoviru
account
much
ari
healthi
adult
much
lower
preval
rhinoviru
infect
winter
month
contrast
patient
studi
infect
rhinoviru
suggest
rhinovirus
caus
case
ari
influenza
season
previous
suspect
likewis
rsv
frequent
find
popul
histor
rsv
consid
respiratori
pathogen
primarili
found
children
respons
increas
rate
bronchiol
pneumonia
winter
month
percept
may
part
due
higher
viral
shed
nasal
secret
children
compar
adult
thu
facilit
detect
children
recent
studi
recogn
import
rsv
elderli
popul
adult
underli
malign
cardiopulmonari
diseas
caus
nosocomi
infect
result
concur
studi
identifi
rsv
import
caus
ari
previous
healthi
adult
includ
pcrbase
studi
identifi
rsv
caus
case
influenzalik
ill
neg
find
studywhich
occur
despit
use
sensit
target
pcr
testingar
worth
note
infrequ
detect
human
coronaviru
studi
somewhat
surpris
older
studi
base
mostli
serolog
test
estim
human
coronavirus
account
case
upper
respiratori
ill
infrequ
case
report
describ
sever
diseas
infant
elderli
popul
adult
chronic
pulmonari
diseas
recent
studi
util
pcr
confirm
human
coronaviru
play
import
role
asthma
exacerb
adult
respiratori
outbreak
howev
unabl
confirm
human
coronaviru
contribut
substanti
clinic
signific
ari
healthi
adult
human
metapneumoviru
also
infrequ
identifi
although
human
metapneumoviru
recent
discov
evid
suggest
viru
circul
human
sever
decad
epidemiolog
clinic
characterist
similar
rsv
date
littl
known
contribut
human
metapneumoviru
ari
adult
limit
data
estim
human
metapneumoviru
preval
among
nonhospit
individu
employ
primer
investig
identifi
human
metapneumoviru
case
result
agre
exist
data
suggest
human
metapneumoviru
cocircul
time
influenza
infrequ
caus
ari
healthi
young
adult
limit
pcr
test
note
studi
specimen
test
pcr
underw
multipl
freezethaw
cycl
may
advers
affect
assay
sensit
unlik
standard
cultur
method
pcr
limit
detect
target
agent
sensit
specif
individu
pcr
test
may
vari
depend
target
pathogen
specif
primer
probe
use
possibl
sampl
posit
pcr
result
neg
shell
vial
assay
result
may
repres
fals
posit
howev
studi
pcr
test
result
corrobor
concurr
convent
test
second
rtpcr
assay
addit
previou
noncultur
confirm
posit
pcr
result
laboratori
confirm
product
sequenc
find
import
clinic
implic
earli
studi
establish
correl
circul
influenza
viru
commun
concurr
increas
incid
sever
ari
hospit
pneumonia
influenzaassoci
mortal
led
conclud
influenza
circul
within
commun
patient
specif
clinic
sign
symptom
eg
cough
fever
within
h
onset
symptom
like
influenza
may
benefit
empir
antivir
therapi
reduc
durat
ill
number
influenzaassoci
hospit
howev
recommend
base
retrospect
pool
analysi
antivir
clinic
trial
inclus
criteria
requir
presenc
fever
andor
symptom
fever
may
confer
select
bia
studi
major
clinic
differ
among
common
agentsinfluenza
rhinoviru
rsvwere
presenc
myalgia
influenza
fever
influenza
rsv
find
wheez
examin
associ
rhinoviru
rsv
infect
associ
wheez
rhinoviru
rsv
infect
describ
postul
due
increas
bronchial
reactiv
caus
airway
injuri
diminish
badrenerg
function
ige
product
enhanc
leukocyt
histamin
releas
assess
patient
nonspecif
symptom
influenzalik
ill
addit
clinic
clue
may
use
clinician
consid
benefit
drawback
prescrib
antivir
therapi
expens
may
associ
advers
effect
exampl
adamantan
drug
associ
cnsrelat
advers
event
particularli
elderli
popul
oseltamivir
caus
advers
gastrointestin
effect
conclus
find
demonstr
even
influenza
season
rhinoviru
rsv
preval
must
consid
differenti
diagnosi
adult
ari
prescrib
antivir
medic
human
coronaviru
human
metapneumoviru
appear
play
substanti
role
final
pcr
especi
use
tool
identif
influenza
viral
pathogen
easili
detect
tradit
test
method
